Keerthana Subramanian

Title: Keerthana Subramanian: Innovator in Antimicrobial Peptide Research

Introduction

Keerthana Subramanian is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of antimicrobial treatments through her innovative research. With a total of 2 patents, her work focuses on developing effective solutions against drug-resistant bacteria.

Latest Patents

One of her latest patents is titled "Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria." This patent discloses peptides that comprise an amphiphilic backbone and a cationic heparin-binding motif peptide. These peptides can be utilized in methods of antimicrobial treatment, showcasing their potential in combating resistant strains of bacteria.

Career Highlights

Keerthana Subramanian is affiliated with Northeastern University, where she continues her research and development in the field of antimicrobial peptides. Her work is crucial in addressing the growing concern of antibiotic resistance, making her a valuable asset to the scientific community.

Collaborations

She collaborates with notable colleagues, including Run Chang and Mian Wang, who contribute to her research endeavors. Their combined expertise enhances the impact of her work in the field.

Conclusion

Keerthana Subramanian's innovative research and patents in antimicrobial treatments highlight her dedication to addressing critical health challenges. Her contributions are paving the way for new solutions in the fight against drug-resistant bacteria.